Audax Private Equity, a mid-market focused private equity firm completed an investment in Corrona, a biotechnology company. Financial terms were not disclosed. “Corrona has established itself as a gold standard provider of real-world evidence and is positioned well to expand its service offerings with additional data sources and therapeutic areas. We have been very impressed with the Corrona science and management team and we look forward to partnering with them on this next phase of growth,” Keith Palumbo, Audax Managing Director.